| 引用本文:陶志广.中医肿瘤临床规范化研究中存在的问题及解决思路[J].世界中医药,2009,4(5):. |
|
| 中医肿瘤临床规范化研究中存在的问题及解决思路 |
| Problems and Solutions to Normalized Clinical Treatment of Cancer by Chinese Medicine |
| 投稿时间：2008-12-11 |
| DOI： |
| 中文关键词: 中医肿瘤 临床研究规范化 |
| English Keywords:Chinese treatment for tumor normalization of clinical research |
| 基金项目: |
|
| 摘要点击次数: 1373 |
| 全文下载次数: 1793 |
| 中文摘要: |
| 中医治疗肿瘤取得了较大的成就，但在中医肿瘤临床研究中也存在着不少问题，如证型、用药的规范化问题，疗效的提高及评价问题，以及循证医学对中医肿瘤临床研究的挑战等。这些问题的解决需要统一到《伤寒杂病论》和经方方证上来，因六经赅百病，经方方剂及用药规范，疗效稳定可靠，便于研究，从此着手开展中医肿瘤临床规范化研究必将打开中医肿瘤临床的新局面。 |
| English Summary: |
| In spite of great achievements in treatment of tumors by Chinese medicine, many problems arise regarding categorization of patterns, normalization of medication, improvement and evaluation of effect, challenges raised by evidence-based medicine, etc. In addressing these problems and opening up new dimensions, it is necessary to establish normalized clinical treatment by drawing upon Shang Han Za Bing Lun (Treatise on Cold Damage and Miscellaneous Diseases) and classical formulas, for all diseases fall into the category of six-meridian syndrome, and classic formulas are normalized in medication, stable in effectiveness, easily accessible for research. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|
